Abbott pioneered the breakthrough MitraClip therapy, which provides unmatched TMVr efficacy.1-4
Patient well-being is at the core of everything we do.
And it’s where our unwavering focus will always
be. Because like you, we’re relentlessly
dedicated to restoring healthy hearts that are
filled with possibilities. And ready to make a
lifetime of cherished memories.
A condition in which the mitral valve does not close completely during contraction of the left ventricle, causing blood to leak backward into the left atrium.
A narrowing of the aortic valve, which reduces or blocks blood flow from the left ventricle to the aorta.
Interventions to prevent thrombus formation include percutaneous closure of the left atrial appendage (LAA) and the patent foramen ovale (PFO).
Congenital heart defects can involve the walls of the heart, the heart valves, and arteries and veins near the heart, disrupting normal blood flow.
Amplatzer PFO Occluder created the category of PFO occlusion, sustained leadership over decades of use, and was the first device supported by positive PFO trial results.
The testimonials relate to accounts of individuals’ responses to treatments. The patients’ accounts are genuine, typical and documented. However, it does not provide any indication, guide, warranty, or guarantee as to the response other persons may have to the treatment. Responses to the treatment discussed can and do vary and are specific to the individual patient.
Derek, who had atrial fibrillation and whose left atrial appendage (LAA) contributed to a stroke, was treated with anticoagulants—but they resulted in a cerebral hemorrhage. David Hildick-Smith, MD, noted that Amplatzer LAA occlusion “reduces the risk of stroke very substantially, but it also offers patients a peace of mind [when they otherwise are] unprotected from the risk of stroke.”
“It’s scary,” said Alan, who had had a stroke due to a patent foramen ovale, and who didn’t know if and when he might have a recurrent stroke. After Amplatzer PFO closure “He’s like a new man,” his wife, Emma, remarked about Alan, who’s back to walking 12 miles a day as a mail carrier. “And I owe everyone a massive thank you,” Alan said.
Over time Jozef’s ventricular septal defect (VSD) precipitated endocarditis, which in turn led to heart failure and kidney failure. After receiving the Amplatzer VSD Occluder Jozef, amazed at his symptom improvement and ability to walk long distances again, said “I feel joy deep inside me—inside my heart.”
“It was so successful in terms of symptom relief, and his recovery was astoundingly quick,” explained Dave Smith, MD, interventional cardiologist who treated Gareth with the Portico valve. “My life is back, and I can do everything now,” said Gareth.
“I couldn’t walk anymore, I couldn’t climb stairs, I couldn’t do anything,” said Alessandro. After receiving MitraClip which eliminated his mitral regurgitation, “I started to feel well, my breathing was good again, and I could return to cutting grass with a scythe—really my life had begun again.”
AP2947148-WBO Rev. A
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.